These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8807124)

  • 1. Idiopathic hyperammonemia: a frequently lethal complication of bone marrow transplantation.
    Davies SM; Szabo E; Wagner JE; Ramsay NK; Weisdorf DJ
    Bone Marrow Transplant; 1996 Jun; 17(6):1119-25. PubMed ID: 8807124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Idiopathic hyperammonemia following allogeneic bone marrow transplantation for refractory lymphoma].
    Watanabe R; Okamoto S; Asahi A; Mori T; Takayama N; Ikeda Y
    Rinsho Ketsueki; 2000 Dec; 41(12):1285-8. PubMed ID: 11201156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic hyperammonemia following an unrelated cord blood transplant for mucopolysaccharidosis I.
    Snyder MJ; Bradford WD; Kishnani PS; Hale LP
    Pediatr Dev Pathol; 2003; 6(1):78-83. PubMed ID: 12481230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral varicella-zoster after bone marrow transplantation: report of a case series and review of the literature.
    David DS; Tegtmeier BR; O'Donnell MR; Paz IB; McCarty TM
    Am J Gastroenterol; 1998 May; 93(5):810-3. PubMed ID: 9625133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation.
    Safadi R; Or R; Ilan Y; Naparstek E; Nagler A; Klein A; Ketzinel-Gilaad M; Ergunay K; Danon D; Shouval D; Galun E
    Bone Marrow Transplant; 2001 Jan; 27(2):183-90. PubMed ID: 11281388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases.
    Bleggi-Torres LF; de Medeiros BC; Werner B; Neto JZ; Loddo G; Pasquini R; de Medeiros CR
    Bone Marrow Transplant; 2000 Feb; 25(3):301-7. PubMed ID: 10673702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
    Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemia.
    Bassan R; Raimondi R; Lerede T; D'emilio A; Buelli M; Borleri G; Personeni A; Bellavita P; Rodeghiero F; Barbui T
    Haematologica; 1998 Jul; 83(7):627-35. PubMed ID: 9718868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matched unrelated donor marrow transplantation in patients with advanced acute leukemia.
    Greinix HT; Reiter E; Schulenburg A; Keil F; Lechner K; Fischer G; Rosenmayr A; Leitner G; Kalhs P
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S53-6. PubMed ID: 9916636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma ammonia in patients with acute leukemia.
    Xu SR; Yao EG; Dong ZR; Liu RS; Pan L; Lin FR; Zhang RX; Liu MC; Ma BB; Yin JQ
    Chin Med J (Engl); 1992 Sep; 105(9):713-6. PubMed ID: 1288971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy.
    Lewis ID; DeFor T; Weisdorf DJ
    Bone Marrow Transplant; 2000 Sep; 26(5):539-43. PubMed ID: 11019844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
    Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group.
    Takenaka K; Gondo H; Tanimoto K; Nagafuji K; Fujisaki T; Mizuno S; Miyamoto T; Okamura T; Hayashi S; Eto T; Osaki K; Yamasaki K; Shibuya T; Harada N; Teshima T; Matsuishi E; Minematsu T; Minamishima Y; Harada M; Niho Y
    Bone Marrow Transplant; 1997 Feb; 19(3):241-8. PubMed ID: 9028553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A syndrome of irreversible leukoencephalopathy following pediatric allogeneic bone marrow transplantation.
    Minn AY; Fisher PG; Barnes PD; Dahl GV
    Pediatr Blood Cancer; 2007 Feb; 48(2):213-7. PubMed ID: 16365853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions.
    Cwynarski K; Goulding R; Pocock C; Dazzi F; Craddock C; Kaeda J; Olavarria E; Kanfer E; Apperley J; Lawler M; Goldman JM
    Bone Marrow Transplant; 2001 Sep; 28(6):581-6. PubMed ID: 11607771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation.
    Anderson JE; Appelbaum FR; Schoch G; Barnett T; Chauncey TR; Flowers ME; Storb R
    Biol Blood Marrow Transplant; 2001; 7(3):163-70. PubMed ID: 11302550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.